Downstream neurodegeneration in Alzheimer's Disease and dementia refers to the progressive spread of neuronal damage from initially affected brain regions to interconnected regions over time. In Alzheimer's, this process starts with the accumulation of beta-amyloid plaques and tau tangles in specific areas responsible for memory and cognition. As these abnormal proteins spread, they disrupt neuronal communication and trigger inflammation, leading to further cell death and cognitive decline.
The spread of neurodegeneration follows neural pathways, affecting regions involved in functions such as language, executive function, and eventually motor control as the disease advances. Understanding this process is crucial for developing treatments that not only target early symptoms but also slow or halt the progression of neurodegeneration across the brain. Research focuses on identifying biomarkers and therapeutic strategies aimed at intervening in these cascading processes to preserve cognitive function and quality of life in affected individuals.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Association between APOE allele prevalence and Alzheimer's disease risk in Southwestern Uganda
Frank Balikoowa, African Research Center for Ageing & Dementia, Uganda
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia
Title : Association between depressive symptoms and cognitive impairment severity in a real-world memory clinic cohort
Yun Ju Hsieh, Taipei City Hospital, Taiwan
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China